Abstract
The determination of the extent of the non-viable tissue after myocardial infarction has a major impact on further treatment of patients. During acute myocardial infarction, total sodium content of the tissue is elevated. This is caused by discontinuation of ion homeostasis, edema formation and membrane rupture. The situation is a different one in the chronic phase of scar formation, where cell migration causes changes in the ratio of extra- and intracellular volume. The accumulation of sodium causes an increase in the signal in 23Na magnetic resonance imaging. The differences in intra- and extracellular sodium concentration modulate total sodium content and can be used as a natural, intrinsic contrast. In animal experiments, 23Na magnetic resonance imaging allows the non-invasive determination of infarct size. As neither stunned nor hibernating tissue shows elevated total sodium content of the tissue, the method is able to discriminate viable and non-viable tissue. A small number of initial clinical studies show promising results for the use of this technique in humans. The development of 23Na magnetic resonance imaging and the current status of the application are described.
Keywords: Magnetic Resonance Imaging, myocardial viability, myocardial infarction, ion homeostasis
Current Vascular Pharmacology
Title: 23Na Magnetic Resonance Imaging for the Determination of Myocardial Viability: The Status and the Challenges
Volume: 2 Issue: 4
Author(s): Michael Horn
Affiliation:
Keywords: Magnetic Resonance Imaging, myocardial viability, myocardial infarction, ion homeostasis
Abstract: The determination of the extent of the non-viable tissue after myocardial infarction has a major impact on further treatment of patients. During acute myocardial infarction, total sodium content of the tissue is elevated. This is caused by discontinuation of ion homeostasis, edema formation and membrane rupture. The situation is a different one in the chronic phase of scar formation, where cell migration causes changes in the ratio of extra- and intracellular volume. The accumulation of sodium causes an increase in the signal in 23Na magnetic resonance imaging. The differences in intra- and extracellular sodium concentration modulate total sodium content and can be used as a natural, intrinsic contrast. In animal experiments, 23Na magnetic resonance imaging allows the non-invasive determination of infarct size. As neither stunned nor hibernating tissue shows elevated total sodium content of the tissue, the method is able to discriminate viable and non-viable tissue. A small number of initial clinical studies show promising results for the use of this technique in humans. The development of 23Na magnetic resonance imaging and the current status of the application are described.
Export Options
About this article
Cite this article as:
Horn Michael, 23Na Magnetic Resonance Imaging for the Determination of Myocardial Viability: The Status and the Challenges, Current Vascular Pharmacology 2004; 2 (4) . https://dx.doi.org/10.2174/1570161043385574
DOI https://dx.doi.org/10.2174/1570161043385574 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Ischemic Cardiovascular Diseases: Mechanisms, Diagnosis and Therapy
Ischemic cardiovascular disease includes myocardial infarction, coronary atherosclerotic heart disease, angina pectoris, etc., constitute the leading cause of patient mortality by preventing tissues from getting sufficient oxygen and nutrients. Ischemic heart disease, as a clinical condition, is characterized by myocardial ischemia, causing an imbalance between myocardial blood supply and demand, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Contribution of Catecholamine Reactive Intermediates and Oxidative Stress to the Pathologic Features of Heart Diseases
Current Medicinal Chemistry Effects of Medroxyprogesterone Acetate on the Risk of Cardiovascular Disease in Postmenopausal Women Receiving Estrogen
Vascular Disease Prevention (Discontinued) Pharmacological Management of No Reflow During Percutaneous Coronary Intervention
Current Vascular Pharmacology B-Type Natriuretic Peptide for Diagnosis and Therapy
Recent Patents on Cardiovascular Drug Discovery Vorapaxar, a Protease-Activated Receptor-1 Antagonist, a Double –Edged Sword!
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Angiotensin 1-7 Promotes Cardiac Angiogenesis Following Infarction
Current Vascular Pharmacology Non-Invasive Imaging of Human Embryonic Stem Cells
Current Pharmaceutical Biotechnology Renin Angiotensin System (RAS) and Immune System Profile in Specific Subgroups with COVID-19
Current Medicinal Chemistry Urine IL-18 is a Biomarker of Early Acute Kidney Injury (AKI)
Recent Patents on Biomarkers NAD<sup>+</sup>/NADH Metabolism and NAD<sup>+</sup>-Dependent Enzymes in Cell Death and Ischemic Brain Injury: Current Advances and Therapeutic Implications
Current Medicinal Chemistry p-Benzoquinone as a Privileged Scaffold of Pharmacological Significance: A Review
Mini-Reviews in Medicinal Chemistry Modulation of Neutrophil Function by Hormones
Current Immunology Reviews (Discontinued) Acute Physical Stress Increases Serum Levels of Specific microRNAs
MicroRNA Targets Involved in Cardioprotection by the Non-Anesthetic Noble Gas Helium
Current Drug Targets Cross-Talk Between NO and Arachidonic Acid in Inflammation
Current Medicinal Chemistry Peripartum Cardiomyopathy: An Intensivist's Perspective
Current Women`s Health Reviews Vascular and Endothelial Regeneration
Current Stem Cell Research & Therapy Regulation of Angiogenesis and Angiogenic Factors by Cardiovascular Medications
Current Pharmaceutical Design Inflammatory Cytokines and Cardiovascular Disease
Current Drug Targets - Inflammation & Allergy Coronary Microcirculation in Ischemic Heart Disease
Current Pharmaceutical Design